Back to Search Start Over

Enhanced signaling downstream of ribonucleic Acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets.

Authors :
Ladrière, Laurence
Igoillo Esteve, Mariana
Andrade Da Cunha, Daniel
Brion, Jean Pierre
Bugliani, Marco
Marchetti, Piero
Eizirik, Decio L.
Cnop, Miriam
Ladrière, Laurence
Igoillo Esteve, Mariana
Andrade Da Cunha, Daniel
Brion, Jean Pierre
Bugliani, Marco
Marchetti, Piero
Eizirik, Decio L.
Cnop, Miriam
Source :
The Journal of clinical endocrinology and metabolism, 95 (3
Publication Year :
2010

Abstract

Background: Free fatty acids cause pancreatic beta-cell apoptosis and may contribute to beta-cell loss in type 2 diabetes via the induction of endoplasmic reticulum (ER) stress. Eukaryotic translation initiation factor 2alpha (eIF2alpha) phosphorylation is an adaptive response to ER stress, and reductions in eIF2alpha phosphorylation trigger beta-cell failure. Salubrinal inhibits eIF2alpha dephosphorylation and has been proposed as a novel therapy for diabetes. Objective: The objective of the study was to examine whether salubrinal modulates human islet susceptibility to lipotoxicity. Study Design: Human islets were treated with oleate or palmitate, alone or in combination with salubrinal, and examined for apoptosis, ultrastructure, and gene expression. Results: Salubrinal enhanced signaling downstream of eIF2alpha and markedly induced the proapoptotic transcription factor CCAAT/enhancer-binding protein homologous protein, but it did not induce the inositol requiring-1alpha or activating transcription factor 6 ER stress pathways. Salubrinal potentiated the deleterious effects of oleate and palmitate in human islets. This proapoptotic effect involved ER dilation and mitochondrial rounding and fragmentation. Conclusions: Excessive eIF2alpha phosphorylation is poorly tolerated by human islets and exacerbates fatty acid-induced apoptosis through ER and mitochondrial mechanisms. This should be taken into consideration when designing approaches to pharmacologically modulate the beta-cell ER stress response in type 2 diabetes.<br />Journal Article<br />Research Support, Non-U.S. Gov't<br />info:eu-repo/semantics/published

Details

Database :
OAIster
Journal :
The Journal of clinical endocrinology and metabolism, 95 (3
Notes :
2 full-text file(s): application/pdf | application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn778635693
Document Type :
Electronic Resource